Biological Age Predicts Future Depression and Anxiety, Even in a Half-Million-Person Cohort

A 2023 Nature Communications study tracking 424,299 UK Biobank participants for a median of 8.7 years found that people who were biologically older than their chronological age had higher risk of developing depression and anxiety. The signal held using two clinical-trait aging algorithms (KDM-BA and PhenoAge), suggesting that accelerated biological aging is not just a reflection of mental health, it may be a measurable risk state that precedes it. The practical impact is straightforward: if biological age can be shifted through modifiable behaviors and environments, mental health prevention may need to treat aging biology as part of the upstream target.

What Researchers Found

The UK Biobank analysis by Gao, Geng, Jiang, et al. (2023) examined whether baseline biological age predicted future onset of depression and anxiety. Rather than relying on self-perceived aging, the team used established biological age estimators derived from routine clinical traits, specifically KDM-BA and PhenoAge, then followed participants prospectively for incident outcomes.

At baseline, participants who were biologically older were more likely to report depression and anxiety. More importantly for causality direction, during follow-up those who started out biologically older also showed higher subsequent risk of developing these conditions. This prospective design reduces, but does not eliminate, the possibility that the association is purely reverse causation (mental health worsening health behaviors and biomarkers).

The study’s scale matters. With over 424,000 participants and nearly a decade of follow-up, small biases can still exist, but random noise is less likely to explain the overall pattern. The repeated finding across two different biological age algorithms also suggests the association is not a quirk of one specific model (Gao et al., 2023, Nature Communications).

Why This Matters for Healthspan

Mental health is often discussed as a separate lane from cardiometabolic risk, inflammation, or neurodegeneration. This paper supports a more integrated view: depression and anxiety can be downstream of the same biological drift that drives chronic disease.

For healthspan, the implication is not that mood disorders are simply “aging.” It is that the body’s cumulative physiological wear and tear may be measurable before clinical symptoms appear, potentially opening an earlier prevention window. If biological age captures multi-system strain (metabolic, inflammatory, vascular, hepatic, renal), then reducing that strain may lower not only heart disease risk but also vulnerability to depression and anxiety.

This also reframes screening. Many people at risk for future mental health decline may not look “high risk” psychologically. They may look high risk biologically, with subtle changes in clinical markers that collectively push biological age upward.

The Mechanism

Biological age algorithms such as PhenoAge and KDM-BA typically integrate signals from multiple systems, including metabolic function, immune and inflammatory activity, and organ performance. Mechanistically, several aging hallmarks plausibly connect these systems to mood regulation.

A 2023 review in Antioxidants by Maldonado, Morales, Urbina, et al. describes how oxidative stress interacts with recognized hallmarks of aging, including mitochondrial dysfunction, genomic instability, epigenetic alterations, and dysregulated nutrient sensing. These processes are not confined to muscles or arteries. They also affect the brain through:

• Energy availability and mitochondrial signaling, which can shape neurotransmitter synthesis and neuronal resilience
• Inflammatory tone, which can alter microglial activation and synaptic remodeling
• Vascular and endothelial function, influencing cerebral blood flow and blood-brain barrier integrity

In parallel, a 2024 review on aging mechanisms and anti-aging strategies (Li, Tian, Luo, et al., Cell Communication and Signaling) summarizes how age-related changes in cellular maintenance systems can propagate systemic dysfunction. When these changes accumulate, the brain may become less tolerant of stressors such as poor sleep, social isolation, illness, or metabolic disruption. The result can be a lower threshold for anxiety and depressive episodes, even without a single obvious trigger.

Context and Limitations

This is observational evidence, not a randomized intervention. Biological age here is a risk marker, and while the prospective design strengthens temporal inference, unmeasured confounding remains possible. For example, early subclinical mental health changes could influence sleep, activity, alcohol use, and inflammation, raising biological age estimates before formal diagnosis.

Another limitation is that biological age algorithms are only as good as the variables they include. They may partially reflect socioeconomic factors, medication use, or comorbidities that also affect mental health risk. The study still matters because it demonstrates that a composite of routine clinical traits can stratify future risk, but it does not prove that lowering biological age will necessarily prevent depression or anxiety (Gao et al., 2023).

Practical Implications

If you are using healthspan strategy to reduce long-term risk, this study supports treating biological aging metrics as mental health relevant, not just cardiovascular relevant. Consider discussing with a clinician whether routine labs and clinical traits that feed aging risk (metabolic markers, inflammation-related markers, organ function indicators) are trending in a favorable direction over time.

From a behavior standpoint, the most defensible takeaway is to prioritize interventions that broadly improve multi-system physiology, since that is what biological age attempts to summarize:

• Sleep regularity (timing consistency, sufficient duration, minimized fragmentation)
• Aerobic and resistance training as foundational “systems medicine”
• Cardiometabolic risk reduction (blood pressure, glucose regulation, lipids)
• Stress load management through sustainable routines and social support

These are not mental health treatments. They are upstream resilience builders that may shift the biological substrate on which mental health depends. For Lifelyx, the larger story is that the next generation of prevention could unify mood, cognition, and chronic disease under one measurable umbrella: the pace of biological aging.